{"data":{"id":"us-in/ic-27-13-38-2","jurisdiction":"us-in","citation":"IC 27-13-38-2","heading":"Substitution of brand name drugs","body":"Sec. 2. Subject to IC 16-42-22:\n(1) a pharmacist shall not substitute; and\n(2) a health maintenance organization shall not require the substitution of;\na different single source brand name drug for a single source brand name drug written on a prescription form or electronically transmitted to a pharmacy unless the substitution is approved by the prescribing provider.","path":["TITLE 27. INSURANCE","ARTICLE 13. HEALTH MAINTENANCE ORGANIZATIONS","Chapter 38. Patient Protection; Drugs and Devices; Drug Utilization Review Program"],"source_url":"https://iga.in.gov/ic/2026/Title_27.html#27-13-38-2","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-25T05:39:04Z","sha256":"ce9c02362b0bde733cc1876aca54e4667a91782e2c54544abc3b5b0bbbacd31d","source_id":"us-in","stale":false,"prev":"us-in/ic-27-13-38-1","next":"us-in/ic-27-13-38-3"},"notice":"GroundRules: Original legal text. Not legal advice."}